Methanol extract of Cordyceps pruinosa inhibits in vitro and in vivo inflammatory mediators by suppressing NF-κB activation

Toxicology and Applied Pharmacology

Volumn 190, Issue 1, 2003, Pages 1-8

  Kim, Ki Mo ^a   Kwon, Young Guen ^a   Chung, Hun Taeg ^b   Yun, Young Gab ^b   Pae, Hyun Ock ^b   Han, Jeong A ^a   Ha, Kwon Soo ^a   Kim, Tae Woong ^a   Kim, Young Myeong ^a  

^a Kangwon National University   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CORDYCEPS PRUINOSA EXTRACT; CYCLOOXYGENASE 2; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; METHANOL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD LEVEL; CELL STIMULATION; CONTROLLED STUDY; CORDYCEPS PRUINOSA; CYTOKINE PRODUCTION; DRUG MECHANISM; FEMALE; GENE EXPRESSION REGULATION; GENE REPRESSION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MEDIATOR; MEDICINAL PLANT; MOUSE; NONHUMAN; PROSTAGLANDIN SYNTHESIS; PROTEIN DETERMINATION;

CORDYCEPS; CORDYCEPS PRUINOSA; MURINAE;

EID: 0038385029     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(03)00152-2     Document Type: Article

References (36)

1. Ahmad N., Chen L.C., Gordon M.A., Laskin J.D., Laskin D.L. Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia. J. Leukocyte Biol. 71:2002;1005-1011.
2. Bertolini A., Ottani A., Sandrini M. Dual acting anti-inflammatory drugs a reappraisal . Pharmacol. Res. 44:2001;437-450.
3. Coker R.K., Laurent G.J. Pulmonary fibrosis cytokines in the balance . Eur. Respir. J. 11:1998;1218-1221.
4. De Nardin E. The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease. Ann. Periodontol. 6:2001;30-40.
5. Han J.W., Lee B.G., Kim Y.K., Joon J.W., Jin H.K., Hong S., Lee H.Y., Lee K.R., Lee H.W. Ergolide, sesquiterpene lactone from Inula britannica, inhibits inducible nitric oxide synthase and cyclo-oxygenase-2 expression in RAW264.7 macrophages through the inactivation of NF-κB. Br. J. Pharmacol. 133:2001;503-512.
6. Hehner S.P., Heinrich M., Bork P.M., Vogt M., Ratter F., Lehmann V., Schulze-Osthoff K., Droge W., Schmitz M.L. Sesquiterpene lactones specifically inhibit activation of NF-κB by preventing the degradation of IκB-α and IκB-β J. Biol. Chem. 273:1998;1288-1297.
7. Heiss E., Herhaus C., Klimo K., Bartsch H., Gerhauser C. Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J. Biol. Chem. 276:2001;32008-32015.
8. Isomaki P., Punnonen J. Pro and anti-inflammatory cytokines in rheumatoid arthritis. Ann. Med. 29:1997;499-507.
9. Kim Y.M., de Vera M.E., Watkins S.C., Billiar T.R. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J. Biol. Chem. 272:1997;1402-1411.
10. Kim Y.M., Talanian R.V., Li J., Billiar T.R. Nitric oxide prevents IL-1beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1beta-converting enzyme). J. Immunol. 15:1998;4122-4128.
11. Krishnaswamy G., Kelley J., Yerra L., Smith J.K., Chi D.S. Human endothelium as a source of multifunctional cytokines molecular regulation and possible role in human disease . J. Interferon Cytokine Res. 19:1999;91-104.
12. Kroncke K.D., Fehsel K., Kolb-Bachofen V. Nitric oxide cytotoxicity versus cytoprotection: how, why, when, and where? Nitric Oxide. 1:1997;107-120.
13. Kuo Y.C., Tsai W.J., Wang J.Y., Chang S.C., Lin C.Y., Shiao M.S. Regulation of bronchoalveolar lavage fluids cell function by the immunomodulatory agents from Cordyceps sinensis. Life Sci. 68:2001;1067-1082.
14. Laskin D.L., Pendino K.J. Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35:1995;655-677.
15. Lawrence T., Gilroy D.W., Colville-Nash P.R., Willoughby D.A. Possible new role for NF-κB in the resolution of inflammation. Nat. Med. 7:2001;1291-1297.
16. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation. 105:2000;1135-1143.
17. Makarov S.S. NF-κB as a therapeutic target in chronic inflammation recent advances . Mol. Med. Today. 6:2000;441-448.
18. Ma Q., Kinneer K. Chemoprotection by phenolic antioxidants inhibition of tumor necrosis factor alpha induction in macrophages . J. Biol. Chem. 277:2002;2477-2484.
19. Mojena M., Hortelano S., Castrillo A., Diaz-Guerra M.J., Garcia-Barchino M.J., Saez G.T., Bosca L. Protection by nitric oxide against liver inflammatory injury in animals carrying a nitric oxide synthase-2 transgene. FASEB J. 15:2001;583-585.
20. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide physiology, pathophysiology, and pharmacology . Pharmacol. Rev. 43:1991;109-142.
21. Park J.P., Kim S.W., Hwang H.J., Yun J.W. Optimization of submerged culture conditions for the mycelial growth and exo-biopolymer production by Cordyceps militaris. Lett. Appl. Microbiol. 33:2001;76-81.
22. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am. J. Cardiol. 18:2001;10K-15K.
23. Renard P., Raes M. The proinflammatory transcription factor NF-κB a potential target for novel therapeutical strategies . Cell Biol. Toxicol. 15:1999;341-344.
24. Riehemann K., Behnke B., Schulze-Osthoff K. Plant extracts from stinging nettle (Urtica dioica), an antirheumatic remedy, inhibit the proinflammatory transcription factor NF-κB. FEBS Lett. 442:1999;89-94.
25. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., Lee L., Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase- 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA. 91:1994;12013-12017.
26. Shapira L., Soskolne W.A., Houri Y., Barak V., Halabi A., Stabholz A. Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline correlation with inhibition of cytokine secretion . Infect. Immun. 64:1996;825-828.
27. Suh N., Honda T., Finlay H.J., Barchowsky A., Williams C., Benoit N.E., Xie Q.W., Nathan C., Gribble G.W., Sporn M.B. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res. 58:1998;717-723.
28. Surh, Y.J., Chun, K.S., Cha, H.H., Han, S.S., Keum, Y.S., Park, K.K., Lee, S.S. (2001). Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat. Res. 480-481, 43-268.
29. Tilg H., Wilmer A., Vogel W., Herold M., Nolchen B., Judmaier G., Huber C. Serum levels of cytokines in chronic liver diseases. Gastroenterology. 103:1992;264-274.
30. Wadsworth T.L., Koop D.R. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem. Pharmacol. 57:1999;941-949.
31. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.
32. Yamaguchi Y., Kagota S., Nakamura K., Shinozuka K., Kunitomo M. Antioxidant activity of the extracts from fruiting bodies of cultured Cordyceps sinensis. Phytother. Res. 14:2000;647-679.
33. Yamamoto Y., Gaynor R.B. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107:2001;135-142.
34. Yu S.M., Wu J.F., Lin T.L., Kuo S.C. Inhibition of nitric oxide synthase expression by PPM-18, a novel anti-inflammatory agent, in vitro and in vivo. Biochem. J. 328:1997;363-369.
35. Zhu J.S., Halpern G.M., Jones K. The scientific rediscovery of an ancient Chinese herbal medicine Cordyceps sinensis: part I . J. Altern. Complement. Med. 4:1998;289-303.
36. Zhu J.S., Halpern G.M., Jones K. The scientific rediscovery of a precious ancient Chinese herbal regimen Cordyceps sinensis: part II . J. Altern. Complement. Med. 4:1998;429-457.